C Wheeler

896 citations

23 papers · 686 indexed · h-index 12

Impact in

Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Oncology top 10%
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research

Papers in ⓘ

Oncology 16
- Cancer Treatment and Pharmacology 7
- Cancer Cells and Metastasis 4
- Lung Cancer Research Studies 3
Hematology 8
- Hematopoietic Stem Cell Transplantation 8

Co-authors: E Frei (6 shared papers)Anthony Elias (11 shared papers)Lois Ayash (11 shared papers)Lowell E. Schnipper (8 shared papers)Paul G. Richardson (3 shared papers)Lynne Uhl (2 shared papers)Karen H. Antman (8 shared papers)W M Hryniuk (1 shared paper)
Journals: Journal of Clinical Oncology (5 papers)Transfusion (3 papers)Bone Marrow Transplantation (2 papers)Stem Cells (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States Germany

In The Last Decade

C Wheeler

23 papers receiving 655 citations

Peers

Countries citing papers authored by C Wheeler

Since Specialization

Citations

This map shows the geographic impact of C Wheeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Wheeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Wheeler more than expected).

Fields of papers citing papers by C Wheeler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Wheeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Wheeler. The network helps show where C Wheeler may publish in the future.

Co-authors

The 25 scholars most cited alongside C Wheeler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C Wheeler Line = papers co-authored together C Wheeler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components Transfusion ·Donna L Fountain, Maria S. Ralston, Nancy Higgins, Jed B. Gorlin, Lynne Uhl, C Wheeler, JH Antin, Churchill Wh, R.J. Benjamin	1997	124
2	Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. Journal of Clinical Oncology ·Lois Ayash, C Wheeler, Diane L. Fairclough, G Schwartz, E Reich, D Warren, Lowell E. Schnipper, Karen H. Antman, E Frei, Alby Elias	1995	99
3	The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity. PubMed ·E Frei, Anthony Elias, C Wheeler, Paul G. Richardson, W M Hryniuk	1998	78
4	A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma Bone Marrow Transplantation ·Pat Stiff, R. Gingrich, Selina M. Luger, MR Wyres, R.A. Brown, CF LeMaistre, James J. Perry, Schenkein Dp, Alan F. List, JR Mason, Jack W. Singer, C Wheeler, Carl E. Freter, WRL Parker, Christos Emmanouilides	2000	72
5	A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity. PubMed ·J P Eder, C Wheeler, Beverly A. Teicher, L E Schnipper	1991	51
6	Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield Transfusion ·R.J. Benjamin, L. Linsley, Donna L Fountain, W. D. Churchill, Colin A. Sieff, M.E. Cannon, Lynne Uhl, Lisa Gaynes, J.H. Antin, C Wheeler	1997	46
7	Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer JNCI Journal of the National Cancer Institute ·Anthony Elias, Lois Ayash, Emil Frei, Arthur T. Skarin, M Hunt, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, I Tepler, Joseph P. Eder, Mark McCauley, Terence S. Herman, Lowell E. Schnipper, K. H. Antman	1993	44
8	Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin. Journal of Clinical Oncology ·Lois Ayash, Anthony Elias, Gary N. Schwartz, C Wheeler, Joseph Ibrahim, Beverly A. Teicher, E Reich, D Warren, C Lynch, Paul G. Richardson, Lowell E. Schnipper, E Frei, Karen H. Antman	1996	43
9	Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte‐colony‐stimulating factor: implications for yield of hematopoietic progenitor cell collections Transfusion ·Iain J. Webb, C. E. Eickhoff, AD Elias, Lois Ayash, C Wheeler, Gary N. Schwartz, George D. Demetri, K C Anderson	1996	18
10	ZD6474, a novel antiangiogenic agent, in combination with docetaxel in patients with NSCLC: Results of the run-in phase of a two-part, randomized phase II study Journal of Clinical Oncology ·John V. Heymach, Runyu Dong, Isaiah W. Dimery, C Wheeler, P. Fidias, C. Lu, Bruce E. Johnson, Roy S. Herbst	2004	17
11	GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols Breast Cancer Research and Treatment ·Anthony Elias, Rosemary Mazanet, C Wheeler, Ken Anderson, Lois Ayash, Gary N. Schwartz, Isidore Tepler, Stephen Pap, Jorge Pelaez, M Hunt, Lowell E. Schnipper, James D. Griffin, Emil Frei, Karen H. Antman	1991	16
12	Phase I dose-escalation study of the highly potent VEGF receptor kinase inhibitor, AZD2171, in patients with advanced cancers with liver metastases Journal of Clinical Oncology ·Michael Medinger, K. Mross, Ute Zirrgiebel, Ralph Strecker, C Wheeler, Glen Clack, Jennifer Lewis, T. A. Puchalski, Clemens Unger, Joachim Drevs	2004	12
13	Phase I dose-escalation study of the highly potent VEGF receptor kinase inhibitor, AZD2171, in patients with advanced cancers with liver metastases Journal of Clinical Oncology ·Michael Medinger, K. Mross, Ute Zirrgiebel, Ralph Strecker, C Wheeler, Glen Clack, Jennifer Lewis, T. A. Puchalski, Clemens Unger, Joachim Drevs	2004	10
14	Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer Blood ·AD Elias, Lois Ayash, KC Anderson, M Hunt, C Wheeler, Gary N. Schwartz, I Tepler, Rosemary Mazanet, C Lynch, Stephen Pap	1992	9
15	The Use of G-CSF or GM-CSF Mobilized Peripheral Blood Progenitor Cells (PBPC) Alone or to Augment Marrow as Hematologic Support of Single or Multiple Cycle High-Dose Chemotherapy Journal of Hematotherapy ·Anthony Elias, Lois Ayash, I Tepler, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, Lowell E. Schnipper, E Frei, Karen H. Antman	1993	8
16	High-Dose Combined Alkylating Agent Therapy With Autologous Stem Cell Support and Chest Radiotherapy for Limited Small-Cell Lung Cancer CHEST Journal ·Anthony Elias, Lois Ayash, Arthur T. Skarin, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, Isidore Tepler, Lowell E. Schnipper, E Frei, Karen H. Antman	1993	8
17	The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses Bone Marrow Transplantation ·Emil Frei, Paul G. Richardson, David Avigan, Craig A. Bunnell, C Wheeler, Anthony Elias	1999	8
18	Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study Journal of Cancer Research and Clinical Oncology ·Anthony Elias, Lois Ayash, J. P. Eder, C Wheeler, Joan Deary, Lisa Weissman, M Hunt, J THOMAS CRITCHLOW, Lowell E. Schnipper, E Frei, Karen H. Antman	1991	6
19	High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age. PubMed ·Karen H. Antman, Lois Ayash, Anthony Elias, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, I Tepler, Schnipper Le, Emil Frei	1994	6
20	GM-CSF mobilized peripheral blood stem cell autografts: The DFCI/BIH experience Stem Cells ·Anthony Elias, Rosemary Mazanet, Kenneth C. Anderson, Lois Ayash, C Wheeler, Gary N. Schwartz, I Tepler, M Hunt, J.D. Critchlow, Lowell E. Schnipper, Emil Frei, Karen H. Antman	1992	5

About C Wheeler

C Wheeler is a scholar working on Oncology, Hematology, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 686 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Cells and Metastasis (4 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Breast Cancer Treatment Studies (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Hematology (203 citations), Oncology (343 citations), Cancer Research (102 citations), Reproductive Medicine (49 citations) and Genetics (60 citations). C Wheeler has collaborated with scholars based in United States and Germany. Frequent co-authors include E Frei, Anthony Elias, Lois Ayash, Lowell E. Schnipper, Paul G. Richardson, Lynne Uhl, Karen H. Antman, W M Hryniuk, Jed B. Gorlin and JH Antin. Their work appears in journals such as Journal of Clinical Oncology, Transfusion, Bone Marrow Transplantation, Stem Cells and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact